₩ 2305
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Access Bio, Inc. engages in the research, development, and manufacture of in-vitro diagnostic tests, immunochemical diagnosis, biosensor, and molecular diagnostic technology. Its products are diagnostic reagents that diagnose infectious diseases such as malaria, influenza, and Coronavirus. The company was founded on September 27, 2002 and is headquartered in Monroe Township, NJ.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is 'expensive' on EV/EBITDA.
Data is available to registered users only